Specificity and heregulin regulation of Ebp1 (ErbB3 binding protein 1) mediated repression of androgen receptor signalling

被引:35
作者
Zhang, Y
Hamburger, AW
机构
[1] Univ Maryland, Ctr Canc, Greenebaum Canc Ctr, Sch Med, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA
关键词
prostate cancer; androgen receptor; ErbB receptors; Ebp1;
D O I
10.1038/sj.bjc.6602257
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although ErbB receptors have been implicated in the progression of prostate cancer, little is known about proteins that may mediate their interactions with the androgen receptor (AR). Ebp1, a protein cloned via its association with the ErbB3 receptor, binds the AR and inhibits androgen-regulated transactivation of wild-type AR in COS cells. As the complement of coregulators in different cells are important for AR activity, we determined the effect of Ebp1 on AR function in prostate cancer cell lines. In addition, we examined the regulation of Ebp1 function by the ErbB3/4 ligand heregulin (HRG). In this study, we demonstrate, using several natural AR-regulated promoters, that Ebp1 repressed transcriptional activation of wild-type AR in prostate cancer cell lines. Downregulation of Ebp1 expression in LNCaP cells using siRNA resulted in activation of AR in the absence of androgen. Ebp1 associated with ErbB3 in LNCaP cells in the absence of HRG, but HRG induced the dissociation of Ebp1 from ErbB3. In contrast, HRG treatment enhanced both the association of Ebp1 with AR and also the ability of Ebp1 to repress AR transactivation. These studies suggest that Ebp1 is an AR corepressor whose biological activity can be regulated by the ErbB3 ligand, HRG.
引用
收藏
页码:140 / 146
页数:7
相关论文
共 46 条
[1]  
Abreu-Martin MT, 1999, MOL CELL BIOL, V19, P5143
[2]   Heparin-binding epidermal growth factor-like growth factor stimulates androgen-independent prostate tumor growth and antagonizes androgen receptor function [J].
Adam, RM ;
Kim, J ;
Lin, JQ ;
Orsola, A ;
Zhuang, LY ;
Rice, DC ;
Freeman, MR .
ENDOCRINOLOGY, 2002, 143 (12) :4599-4608
[3]  
Amler LC, 2000, CANCER RES, V60, P6134
[4]  
Bacus SS, 1996, ONCOGENE, V12, P2535
[5]   EGF receptor (EGFR) signaling promoting invasion is disrupted in androgen-sensitive prostate cancer cells by an interaction between EGFR and androgen receptor (AR) [J].
Bonaccorsi, L ;
Carloni, V ;
Muratori, M ;
Formigli, L ;
Zecchi, S ;
Forti, G ;
Baldi, E .
INTERNATIONAL JOURNAL OF CANCER, 2004, 112 (01) :78-86
[6]   Molecular determinants of resistance to antiandrogen therapy [J].
Chen, CD ;
Welsbie, DS ;
Tran, C ;
Baek, SH ;
Chen, R ;
Vessella, R ;
Rosenfeld, MG ;
Sawyers, CL .
NATURE MEDICINE, 2004, 10 (01) :33-39
[7]   Selective DNA binding by the androgen receptor as a mechanism for hormone-specific gene regulation [J].
Claessens, F ;
Verrijdt, G ;
Schoenmakers, E ;
Haelens, A ;
Peeters, B ;
Verhoeven, G ;
Rombauts, W .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2001, 76 (1-5) :23-30
[8]   A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase [J].
Craft, N ;
Shostak, Y ;
Carey, M ;
Sawyers, CL .
NATURE MEDICINE, 1999, 5 (03) :280-285
[9]  
CULIG Z, 1994, CANCER RES, V54, P5474
[10]   Androgen receptors in prostate cancer [J].
Culig, ZR ;
Klocker, H ;
Bartsch, G ;
Steiner, H ;
Hobisch, A .
JOURNAL OF UROLOGY, 2003, 170 (04) :1363-1369